Skip to main content

Table 2 ICSI outcomes in the study groups

From: Freeze-all policy versus luteal phase support with low dose of human chorionic gonadotrophin for high-responder patients undergoing intracytoplasmic sperm injection on pregnancy outcomes: a retrospective cohort observational study

ICSI cycle outcomes

Group A

(n = 78 )

Group B

(n = 65 )

p-Value

Daily exogenous gonadotrophine dose (UI)

168.3 ± 38.7

165.7 ± 39.9

0.804

E2 level at day of trigger (Pg/Ml)

2330.2 ± 1025.1

3775.6 ± 2161.1

0.262

Endometrial thickness (mm)

10.3 ± 1.6

10.1 ± 1.9

0.814

Retrieved oocytes (n)

12.7 ± 3.2

14.1 ± 3.5

0.158

Mature oocytes (n)

10.2 ± 3.2

11.1 ± 3.7

0.711

Fertilization rate (%)

73.8

76.9

0.456

Embryo transfer (n)

1.2 ± 0.4

1.3 ± 0.4

0.684

Implantation rate (%)

22/78 (28.20%)

28/65 (43.07%)

< 0.001*

Clinical pregnancy rate/first ET%

19/78 (24.35%)

26/65 (40%)

< 0.001*

Live birth rate/first ET%

14/78 (17.94%)

21/65 (32.30%)

< 0.001*

Clinical miscarriage

5/19 (26.05%)

5/26 (19.2%)

< 0.001*

Ectopic pregnancy

0

0

 

Mild OHSS

5/78 (6.41%)

5/65 (7.69%)

0.623

Moderate to severe OHSS

5/78 (6.41%)

0

0.023*

  1. Data are presented as mean (SD), number, and proportion (%). E2, estradiol; ET, embryo transfer; OHSS, ovarian hyperstimulation syndrome. *P < 0.05 is statistically significant